Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Serpasil — SERPASIL
Application NDA009115 (NDA)
Serpasil — SANDRIL
Application NDA010012 (NDA)
Serpasil — SERPASIL
Application NDA009434 (NDA)
Serpasil — HISERPIA
Application NDA009631 (NDA)
Serpasil — RAU-SED
Application NDA009357 (NDA)
Serpasil — RESERPINE
Application NDA009663 (NDA)
Serpasil — RESERPINE
Application NDA009859 (NDA)
Serpasil — RESERPINE
Application NDA010441 (NDA)
Serpasil — RESERPINE
Application NDA009627 (NDA)
Serpasil — RESERPINE
Application NDA011185 (NDA)
Serpasil — RESERPINE
Application NDA009838 (NDA)
Serpasil — RESERPINE
Application NDA009667 (NDA)
Serpasil — SANDRIL
Application NDA009376 (NDA)
Serpasil — SERPALAN
Application NDA010124 (NDA)
Serpasil — SERPANRAY
Application NDA009391 (NDA)
Serpasil — SERPATE
Application NDA009453 (NDA)
Serpasil — SERPIVITE
Application NDA009645 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)